An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB)



Rosenfeld, Margaret, Cunningham, Steve, Harris, William T, Lapey, Allen, Regelmann, Warren E, Sawicki, Gregory S, Southern, Kevin W ORCID: 0000-0001-6516-9083, Chilvers, Mark, Higgins, Mark, Tian, Simon
et al (show 3 more authors) (2019) An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB). JOURNAL OF CYSTIC FIBROSIS, 18 (6). 838 - 843.

[img] Text
1-s2.0-S156919931930061X-main.pdf - OA Published Version

Download (419kB) | Preview
Item Type: Article
Uncontrolled Keywords: (3-6 required): Cystic fibrosis, CFTR potentiator, Ivacaftor, KLIMB, Pediatrics, Safety
Depositing User: Symplectic Admin
Date Deposited: 13 May 2019 08:40
Last Modified: 16 Oct 2021 01:11
DOI: 10.1016/j.jcf.2019.03.009
Open Access URL: https://doi.org/10.1016/j.jcf.2019.03.009
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3040989